RESUMEN
Dowling-Degos disease is a rare benign genodermatosis. It is characterized by lentiginous hyperpigmentation and reddish-brown papules and plaques. The flexor sides and intertrigines are often affected, but the clinical appearance may vary. Mutations in different genes are responsible for the clinical manifestation. While mutations in the keratin 5 (KRT5) gene favor a reticular distribution pattern, mutations in the POGLUT1 gene lead to a disseminated, papular clinical picture. Acantholytic variants of Dowling-Degos disease have historically been referred to as Galli-Galli disease, but our case study shows that the histopathological changes can vary even within a single patient. To date, no standardized therapy concept exists. The main focus is on keratolytic measures, with varying response. New therapeutic approaches using laser technology appear to be a promising treatment option.
Asunto(s)
Hiperpigmentación , Enfermedades Cutáneas Papuloescamosas , Humanos , Acantólisis/diagnóstico , Acantólisis/genética , Acantólisis/patología , Glucosiltransferasas/genética , Hiperpigmentación/genética , Hiperpigmentación/patología , Mutación/genética , Enfermedades Cutáneas Papuloescamosas/diagnóstico , Enfermedades Cutáneas Papuloescamosas/genética , Enfermedades Cutáneas Papuloescamosas/patologíaRESUMEN
Dowling-Degos disease (DDD) is a rare autosomal-dominant genodermatosis and it has been associated with hidradenitis suppurativa (HS). Deregulation of NOTCH pathway has been linked to the development of HS in DDD context (DDD-HS). However, molecular alterations in DDD-HS, including altered gene expression of NOTCH and downstream effectors that are involved in the follicular differentiation and inflammatory response, are poorly defined. We report two cases of patients diagnosed with DDD-HS, one of those, under Adalimumab treatment. Our results have shown downregulation of NOTCH1/NCSTN pathway, distinct molecular profiles of inflammatory cytokines (IL23A and TNF), and a novel aberrant upregulation of genes involved in the cornified envelope (CE) formation (SPRR1B, SPRR2D, SPRR3, and IVL) in paired HS lesions of two DDD patients.
Asunto(s)
Citocinas/metabolismo , Regulación de la Expresión Génica , Hidradenitis Supurativa/patología , Hiperpigmentación/patología , Mediadores de Inflamación/metabolismo , Receptor Notch1/metabolismo , Enfermedades Cutáneas Genéticas/patología , Enfermedades Cutáneas Papuloescamosas/patología , Adulto , Secretasas de la Proteína Precursora del Amiloide/genética , Secretasas de la Proteína Precursora del Amiloide/metabolismo , Proteínas Ricas en Prolina del Estrato Córneo/genética , Proteínas Ricas en Prolina del Estrato Córneo/metabolismo , Femenino , Hidradenitis Supurativa/complicaciones , Hidradenitis Supurativa/genética , Hidradenitis Supurativa/metabolismo , Humanos , Hiperpigmentación/complicaciones , Hiperpigmentación/genética , Hiperpigmentación/metabolismo , Glicoproteínas de Membrana/genética , Glicoproteínas de Membrana/metabolismo , Persona de Mediana Edad , Pronóstico , Receptor Notch1/genética , Enfermedades Cutáneas Genéticas/complicaciones , Enfermedades Cutáneas Genéticas/genética , Enfermedades Cutáneas Genéticas/metabolismo , Enfermedades Cutáneas Papuloescamosas/complicaciones , Enfermedades Cutáneas Papuloescamosas/genética , Enfermedades Cutáneas Papuloescamosas/metabolismoRESUMEN
We reported a Chinese pedigree with scrotal Dowling-Degos disease and evaluated the phenotypic and genotypic characteristics. In affected cases, pigmented macules were identified on the scrotum. The rashes increased, and the colour deepened progressively. No pain or pruritus were noticed, and no other skin folds were involved. Skin histopathology showed characteristic features of Dowling-Degos disease. A heterozygous PSENEN frameshift variant c.292delCï¼p.L98Wfs*47ï¼ was identified in affected cases. The variant was not found in dbSNP, 1000 Genomes project database and the ExAC Browser. The p.L98 and adjacent amino acids are highly conserved among species. Our cases expand the phenotypic and genotypic spectrum of PSENEN-related Dowling-Degos disease.
Asunto(s)
Secretasas de la Proteína Precursora del Amiloide/genética , Mutación del Sistema de Lectura , Hiperpigmentación/genética , Proteínas de la Membrana/genética , Enfermedades Cutáneas Genéticas/genética , Enfermedades Cutáneas Papuloescamosas/genética , Adulto , Pueblo Asiatico , China , Humanos , Masculino , EscrotoAsunto(s)
Anticuerpos Monoclonales Humanizados , Proteínas Adaptadoras de Señalización CARD , Guanilato Ciclasa , Humanos , Proteínas Adaptadoras de Señalización CARD/genética , Anticuerpos Monoclonales Humanizados/uso terapéutico , Guanilato Ciclasa/genética , Proteínas de la Membrana/genética , Fenotipo , Enfermedades Cutáneas Papuloescamosas/tratamiento farmacológico , Enfermedades Cutáneas Papuloescamosas/patología , Enfermedades Cutáneas Papuloescamosas/genética , Fármacos Dermatológicos/uso terapéutico , Masculino , FemeninoAsunto(s)
Hiperpigmentación , Enfermedades Cutáneas Genéticas , Enfermedades Cutáneas Papuloescamosas , Humanos , Transcriptoma/genética , Hiperpigmentación/genética , Hiperpigmentación/patología , Enfermedades Cutáneas Papuloescamosas/diagnóstico , Enfermedades Cutáneas Papuloescamosas/genética , Enfermedades Cutáneas Genéticas/diagnóstico , Enfermedades Cutáneas Genéticas/genética , Enfermedades Cutáneas Genéticas/patologíaRESUMEN
BACKGROUND: Dowling-Degos disease (DDD), featuring reticulate pigmentation, and familial hidradenitis suppurativa (HS) share many clinical features including autosomal dominant inheritance, flexural location and follicular defects. The coexistence of the two disorders was recently found to result from mutations in PSENEN, encoding the γ-secretase subunit protein presenilin enhancer. OBJECTIVES: To investigate PSENEN mutations in a series of four unrelated patients who presented with combined DDD and HS. METHODS: Mutation and haplotype analysis of PSENEN by polymerase chain reaction, and cellular assays investigating the Notch signalling pathway. RESULTS: Here we report four families of Jewish Ashkenazi origin who presented with clinical features characteristic of both disorders. All patients were found to carry the same, heterozygous mutation in PSENEN (c.168T>G, p.Y56X). Haplotype analysis revealed that the mutation originated from a common ancestor. Genes associated with DDD, as well as HS, have been shown to encode important regulators of Notch signalling. Accordingly, using a reporter assay, we demonstrated decreased Notch activity in a patient's keratinocytes. CONCLUSIONS: The present data confirm the genetic basis of the combined DDD-HS phenotype and suggest that Notch signalling may play a central role in the pathogenesis of this rare condition.
Asunto(s)
Secretasas de la Proteína Precursora del Amiloide/genética , Efecto Fundador , Hidradenitis Supurativa/genética , Hiperpigmentación/genética , Proteínas de la Membrana/genética , Mutación/genética , Enfermedades Cutáneas Genéticas/genética , Enfermedades Cutáneas Papuloescamosas/genética , Adulto , Femenino , Humanos , Masculino , Fenotipo , Receptores Notch/genética , Transducción de Señal/genética , Adulto JovenRESUMEN
BACKGROUND: Heterozygous mutations in caspase recruitment domain family member 14 gene (CARD14) have been shown to be associated with psoriasis and familial pityriasis rubra pilaris (PRP). Many subjects with CARD14 mutations display features of both disorders, which can result in diagnostic uncertainty. In addition, these eruptions are often recalcitrant to conventional psoriasis therapies such as methotrexate, oral retinoids, and tumor necrosis factor-α inhibitors. OBJECTIVE: We sought to describe the clinical characteristics, family history, and response to therapy in subjects with papulosquamous eruptions due to mutations in CARD14. METHODS: Subjects were referred for genetic testing as part of a registry of subjects with inherited disorders of keratinization. DNA was isolated from blood or saliva, and multiplex targeted sequencing or whole exome sequencing was performed. Clinical histories of subjects with CARD14 mutations were reviewed. RESULTS: We identified 15 kindreds with CARD14-associated papulosquamous eruption (CAPE). Characteristic features of CAPE include early age of onset; prominent involvement of the cheeks, chin, and ears; family history of psoriasis or PRP; minimal response to conventional topical and systemic psoriasis therapies; and improvement with ustekinumab. LIMITATIONS: Relatively small sample size. CONCLUSIONS: Many subjects with CARD14 mutations display characteristics of both psoriasis and PRP. We propose the term CARD14-associated papulosquamous eruption to describe this spectrum of disease. Subjects with clinical features suggestive of CAPE should undergo CARD14 sequencing and may benefit from treatment with ustekinumab.
Asunto(s)
Proteínas Adaptadoras de Señalización CARD/genética , Fármacos Dermatológicos/uso terapéutico , Dermatosis Facial/genética , Guanilato Ciclasa/genética , Proteínas de la Membrana/genética , Enfermedades Cutáneas Papuloescamosas/tratamiento farmacológico , Enfermedades Cutáneas Papuloescamosas/genética , Ustekinumab/uso terapéutico , Edad de Inicio , Niño , Preescolar , Pruebas Genéticas , Humanos , Lactante , Recién Nacido , Fenotipo , Pitiriasis Rubra Pilaris/genética , Psoriasis/genética , Psoriasis/terapia , RetratamientoRESUMEN
Protein O-fucosyltransferase-1 (POFUT1), which transfers fucose residues to acceptor sites on serine and threonine residues of epidermal growth factor-like repeats of recipient proteins, is essential for Notch signal transduction in mammals. Here, we examine the consequences of POFUT1 loss on the oncogenic signaling associated with certain leukemia-associated mutations of human Notch1, report the structures of human POFUT1 in free and GDP-fucose bound states, and assess the effects of Dowling-Degos mutations on human POFUT1 function. CRISPR-mediated knockout of POFUT1 in U2OS cells suppresses both normal Notch1 signaling, and the ligand-independent signaling associated with leukemogenic mutations of Notch1. Normal and oncogenic signaling are rescued by wild-type POFUT1 but rescue is impaired by an active-site R240A mutation. The overall structure of the human enzyme closely resembles that of the Caenorhabditis elegans protein, with an overall backbone RMSD of 0.93 Å, despite primary sequence identity of only 39% in the mature protein. GDP-fucose binding to the human enzyme induces limited backbone conformational movement, though the side chains of R43 and D244 reorient to make direct contact with the fucose moiety in the complex. The reported Dowling-Degos mutations of POFUT1, except for M262T, fail to rescue Notch1 signaling efficiently in the CRISPR-engineered POFUT1-/- background. Together, these studies identify POFUT1 as a potential target for cancers driven by Notch1 mutations and provide a structural roadmap for its inhibition.
Asunto(s)
Fucosiltransferasas/química , Fucosiltransferasas/genética , Hiperpigmentación/genética , Mutación , Receptores Notch/genética , Receptores Notch/metabolismo , Transducción de Señal/genética , Enfermedades Cutáneas Genéticas/genética , Enfermedades Cutáneas Papuloescamosas/genética , Carcinogénesis/genética , Carcinogénesis/metabolismo , Fucosiltransferasas/deficiencia , Fucosiltransferasas/metabolismo , Humanos , Hiperpigmentación/metabolismo , Ligandos , Conformación Proteica , Enfermedades Cutáneas Genéticas/metabolismo , Enfermedades Cutáneas Papuloescamosas/metabolismoRESUMEN
Dowling-Degos disease (DDD) is an autosomal-dominant genodermatosis characterized by progressive and disfiguring reticulate hyperpigmentation. We previously identified loss-of-function mutations in KRT5 but were only able to detect pathogenic mutations in fewer than half of our subjects. To identify additional causes of DDD, we performed exome sequencing in five unrelated affected individuals without mutations in KRT5. Data analysis identified three heterozygous mutations from these individuals, all within the same gene. These mutations, namely c.11G>A (p.Trp4*), c.652C>T (p.Arg218*), and c.798-2A>C, are within POGLUT1, which encodes protein O-glucosyltransferase 1. Further screening of unexplained cases for POGLUT1 identified six additional mutations, as well as two of the above described mutations. Immunohistochemistry of skin biopsies of affected individuals with POGLUT1 mutations showed significantly weaker POGLUT1 staining in comparison to healthy controls with strong localization of POGLUT1 in the upper parts of the epidermis. Immunoblot analysis revealed that translation of either wild-type (WT) POGLUT1 or of the protein carrying the p.Arg279Trp substitution led to the expected size of about 50 kDa, whereas the c.652C>T (p.Arg218*) mutation led to translation of a truncated protein of about 30 kDa. Immunofluorescence analysis identified a colocalization of the WT protein with the endoplasmic reticulum and a notable aggregating pattern for the truncated protein. Recently, mutations in POFUT1, which encodes protein O-fucosyltransferase 1, were also reported to be responsible for DDD. Interestingly, both POGLUT1 and POFUT1 are essential regulators of Notch activity. Our results furthermore emphasize the important role of the Notch pathway in pigmentation and keratinocyte morphology.
Asunto(s)
Glucosiltransferasas/genética , Hiperpigmentación/genética , Mutación , Enfermedades Cutáneas Genéticas/genética , Enfermedades Cutáneas Papuloescamosas/genética , Adolescente , Adulto , Exoma , Femenino , Estudio de Asociación del Genoma Completo , Heterocigoto , Humanos , Queratinocitos/citología , Queratinocitos/metabolismo , Masculino , Persona de Mediana Edad , Linaje , Conformación Proteica , Análisis de Secuencia de ADN , Piel/patología , Adulto JovenRESUMEN
Reticulate pigmentary disorders are a group of disorders characterized by hyper- and/or hypopigmented macules with varying sizes and amounts of pigment. Some of the disorders are heritable, such as Dowling-Degos disease, dyschromatosis universalis hereditaria, dyschromatosis symmetrica hereditaria, reticulate acropigmentation of Kitamura and X-linked reticulate pigmentary disorder. Although each condition possesses unique phenotypic characteristics and the prognosis for each is somewhat different, there is a large degree of overlap between the disorders and therefore they are difficult to differentiate in the clinical setting. This updated review provides a clinical and molecular delineation of these genetic reticulate pigmentary disorders and aims to establish a concise diagnostic strategy to allow clinical dermatologists to make an accurate diagnosis, as well as to provide useful information for clinical and genetic counselling.
Asunto(s)
Trastornos de la Pigmentación/genética , Enfermedades Cutáneas Genéticas/genética , Diagnóstico Diferencial , Disqueratosis Congénita/diagnóstico , Disqueratosis Congénita/genética , Disqueratosis Congénita/terapia , Diagnóstico Precoz , Epidermólisis Ampollosa Distrófica/diagnóstico , Epidermólisis Ampollosa Distrófica/genética , Epidermólisis Ampollosa Distrófica/terapia , Humanos , Hiperpigmentación/diagnóstico , Hiperpigmentación/genética , Hiperpigmentación/terapia , Mutación/genética , Fenotipo , Trastornos de la Pigmentación/congénito , Enfermedades Cutáneas Genéticas/diagnóstico , Enfermedades Cutáneas Genéticas/terapia , Enfermedades Cutáneas Papuloescamosas/diagnóstico , Enfermedades Cutáneas Papuloescamosas/genética , Enfermedades Cutáneas Papuloescamosas/terapia , Proteínas Supresoras de Tumor/genéticaAsunto(s)
Psoriasis , Enfermedades Cutáneas Papuloescamosas , Proteínas Adaptadoras de Señalización CARD/genética , Exones , Guanilato Ciclasa/genética , Humanos , Hiperpigmentación , Proteínas de la Membrana/genética , Mutación , Psoriasis/complicaciones , Psoriasis/genética , Enfermedades Cutáneas Genéticas , Enfermedades Cutáneas Papuloescamosas/genéticaRESUMEN
Pseudoxanthoma elasticum (PXE) is an autosomal recessive disorder characterized by atypical elastic fibers that causes connective tissue abnormalities of the skin, eyes, and heart, among other organs. The disorder is rare, with a classic presentation of yellow-orange cobblestone-like papules on flexural areas, lax skin, ocular degeneration, and moribund vasculature in multiple organs. There is wide variability in the presentation of the affected organs [1]. We present two sisters with classic cutaneous findings of PXE with the additional unusual findings of numerous open comedones on the neck. To our knowledge, this is the first report of numerous open comedones in familial PXE.
Asunto(s)
Seudoxantoma Elástico/complicaciones , Enfermedades Cutáneas Papuloescamosas/complicaciones , Adulto , Femenino , Humanos , Cuello , Seudoxantoma Elástico/diagnóstico , Seudoxantoma Elástico/genética , Enfermedades Cutáneas Papuloescamosas/genética , Trastornos de la Visión/etiología , Adulto JovenRESUMEN
Dowling-Degos disease (DDD), or reticular pigmented anomaly of the flexures, is a type of rare autosomal-dominant genodermatosis characterized by reticular hyperpigmentation and hypopigmentation of the flexures, such as the neck, axilla, and areas below the breasts and groin, and shows considerable heterogeneity. Loss-of-function mutations of keratin 5 (KRT5) have been identified in DDD individuals. In this study, we collected DNA samples from a large Chinese family affected by generalized DDD and found no mutation of KRT5. We performed a genome-wide linkage analysis of this family and mapped generalized DDD to a region between rs1293713 and rs244123 on chromosome 20 [corrected]. By exome sequencing, we identified nonsense mutation c.430G>T (p.Glu144(∗)) in POFUT1, which encodes protein O-fucosyltransferase 1, in the family. Study of an additional generalized DDD individual revealed the heterozygous deletion mutation c.482delA (p.Lys161Serfs(∗)42) in POFUT1. Knockdown of POFUT1 reduces the expression of NOTCH1, NOTCH2, HES1, and KRT5 in HaCaT cells. Using zebrafish, we showed that pofut1 is expressed in the skin and other organs. Morpholino knockdown of pofut1 in zebrafish produced a phenotype characteristic of hypopigmentation at 48 hr postfertilization (hpf) and abnormal melanin distribution at 72 hpf, replicating the clinical phenotype observed in our DDD individuals. At 48 and 72 hpf, tyrosinase activities decreased by 33% and 45%, respectively, and melanin protein contents decreased by 20% and 25%, respectively. Our findings demonstrate that POFUT1 mutations cause generalized DDD. These results strongly suggest that the protein product of POFUT1 plays a significant and conserved role in melanin synthesis and transport.
Asunto(s)
Fucosiltransferasas/genética , Hiperpigmentación/genética , Mutación Missense , Enfermedades Cutáneas Genéticas/genética , Enfermedades Cutáneas Papuloescamosas/genética , Animales , Mapeo Cromosómico , Cromosomas Humanos Par 20/genética , Femenino , Expresión Génica , Técnicas de Silenciamiento del Gen , Ligamiento Genético , Predisposición Genética a la Enfermedad , Estudio de Asociación del Genoma Completo , Células HEK293 , Humanos , Hiperpigmentación/patología , Melaninas/biosíntesis , Melaninas/genética , Persona de Mediana Edad , Linaje , Polimorfismo de Nucleótido Simple , Análisis de Secuencia de ADN , Enfermedades Cutáneas Genéticas/patología , Enfermedades Cutáneas Papuloescamosas/patología , Pez Cebra , Proteínas de Pez Cebra/biosíntesis , Proteínas de Pez Cebra/genéticaRESUMEN
We present a case of a patient with long-standing hyperpigmented macules and erythematous papules over his chest, abdomen, back and arms, suggestive of Dowling-Degos disease (DDD). In addition, there were hyperkeratotic papules, alternating red and white nail-bed discolouration, and V-shaped nail notching consistent with Darier disease (DD). Histology showed findings consistent with DDD and DD on separate specimens. The lack of acantholysis in areas of filiform hyperpigmented rete ridges ruled out Galli-Galli disease (GGD). DDD results from mutations in the genes encoding keratin 5 (KRT5), protein O-glucosyltransferase 1 (POGLUT1) or protein O-fucosyltransferase 1 (POFUT1), while DD results from mutations in the ATP2A2 gene. Both genes are present on chromosome 12. In this case, the patient presented with features of both DDD and DD, which suggests that either a cooperating mutation or a mutation in an unrelated gene locus may underlie the findings in this patient.
Asunto(s)
Enfermedad de Darier/complicaciones , Enfermedad de Darier/diagnóstico , Enfermedad de Darier/patología , Hiperpigmentación/complicaciones , Hiperpigmentación/diagnóstico , Hiperpigmentación/patología , Enfermedades Cutáneas Genéticas/complicaciones , Enfermedades Cutáneas Genéticas/diagnóstico , Enfermedades Cutáneas Genéticas/patología , Enfermedades Cutáneas Papuloescamosas/complicaciones , Enfermedades Cutáneas Papuloescamosas/diagnóstico , Enfermedades Cutáneas Papuloescamosas/patología , Acantólisis/etiología , Acantólisis/patología , Erupciones Acneiformes/patología , Cromosomas Humanos Par 12/genética , Enfermedad de Darier/genética , Humanos , Hiperpigmentación/genética , Queratinas/genética , Queratinas/fisiología , Masculino , Persona de Mediana Edad , Mutación , Enfermedades de la Uña , Linaje , Enfermedades Cutáneas Genéticas/genética , Enfermedades Cutáneas Papuloescamosas/genéticaRESUMEN
Reticulate acropigmentation of Kitamura (RAK) is a rare genetic disorder of cutaneous pigmentation with an autosomal dominant pattern of inheritance and a high penetration rate. The characteristic skin lesions are reticulate, slightly depressed pigmented macules mainly affecting the dorsa of the hands and feet, which first appear before puberty and subsequently expand to the proximal limb and the trunk. To identify mutations that cause RAK, we performed exome sequencing of four family members in a pedigree with RAK. Fifty-three SNV/Indels were considered as candidate mutations after some condition narrowing. We confirmed the mutation status in each candidate gene of four other members in the same pedigree to find the gene that matched the mutation status and phenotype of each member. A mutation in ADAM10 encoding a zinc metalloprotease, a disintegrin and metalloprotease domain-containing protein 10 (ADAM10), was identified in the RAK family. ADAM10 is known to be involved in the ectodomain shedding of various substrates in the skin. Sanger sequencing of four additional unrelated RAK patients revealed four additional ADAM10 mutations. We identified a total of three truncating mutations, a splice site mutation and a missense mutation in ADAM10. We searched for mutations in the KRT5 gene, a causative gene for the similar pigmentation disorder Dowling-Degos disease (DDD), in all the patients and found no KRT5 mutation. These results reveal that mutations in ADAM10 are a cause of RAK and that RAK is an independent clinical entity distinct from DDD.
Asunto(s)
Proteínas ADAM/genética , Proteínas ADAM/metabolismo , Secretasas de la Proteína Precursora del Amiloide/genética , Secretasas de la Proteína Precursora del Amiloide/metabolismo , Hiperpigmentación/genética , Proteínas de la Membrana/genética , Proteínas de la Membrana/metabolismo , Enfermedades Cutáneas Genéticas/genética , Enfermedades Cutáneas Papuloescamosas/genética , Proteína ADAM10 , Adulto , Anciano , Células Cultivadas , Exoma , Femenino , Humanos , Hiperpigmentación/fisiopatología , Mutación INDEL , Queratina-5/genética , Queratina-5/metabolismo , Masculino , Persona de Mediana Edad , Mutación Missense , Linaje , Filogenia , Análisis de Secuencia de ADN , Análisis de Secuencia de Proteína , Enfermedades Cutáneas Genéticas/fisiopatología , Enfermedades Cutáneas Papuloescamosas/fisiopatología , Adulto JovenRESUMEN
BACKGROUND: Familial comedones without dyskeratosis are a rare autosomal dominant skin disorder, characterized by the occurrence of comedones that are distributed all over the body with specific features. We have previously reported two Thai families with familial comedones with expanded phenotypic spectrum. However, its genetic defect and pathogenesis remain unknown. OBJECTIVE: To explore the molecular defect causing familial comedones. METHODS: Whole-genome linkage analysis and whole-exome sequencing in family I were performed. RESULTS: We identified a heterozygous one-base pair insertion, c.84_85insT (p. L28FfsX93) in PEN-2, located within the linked region on chromosome 19. PCR-Sanger sequencing confirmed the identified mutation. The mutation segregated with the disease phenotype in family I and was fully penetrant. This similar mutation was also present in the unrelated affected individual from family II. Quantitative PCR revealed increased mRNA expression of PEN-2 in leukocytes of affected individuals. CONCLUSION: We for the first time identify PEN-2 as the causative gene of familial comedones.
Asunto(s)
Secretasas de la Proteína Precursora del Amiloide/genética , Mutación del Sistema de Lectura , Proteínas de la Membrana/genética , Anomalías Cutáneas/genética , Enfermedades Cutáneas Papuloescamosas/genética , Cromosomas Humanos Par 19 , Análisis Mutacional de ADN , Exoma/genética , Femenino , Humanos , Masculino , Linaje , FenotipoAsunto(s)
Hiperpigmentación , Enfermedades Cutáneas Genéticas , Enfermedades Cutáneas Papuloescamosas , Vulva/patología , Femenino , Humanos , Hiperpigmentación/diagnóstico , Hiperpigmentación/genética , Persona de Mediana Edad , Enfermedades Cutáneas Genéticas/diagnóstico , Enfermedades Cutáneas Genéticas/genética , Enfermedades Cutáneas Papuloescamosas/diagnóstico , Enfermedades Cutáneas Papuloescamosas/genéticaAsunto(s)
Secretasas de la Proteína Precursora del Amiloide/genética , Hidradenitis Supurativa/genética , Hiperpigmentación/genética , Proteínas de la Membrana/genética , Anomalías Cutáneas/genética , Enfermedades Cutáneas Genéticas/genética , Enfermedades Cutáneas Papuloescamosas/genética , Comorbilidad , Heterocigoto , Hidradenitis Supurativa/epidemiología , Humanos , Hiperpigmentación/epidemiología , Mutación , Fenotipo , Anomalías Cutáneas/epidemiología , Enfermedades Cutáneas Genéticas/epidemiología , Enfermedades Cutáneas Papuloescamosas/epidemiologíaAsunto(s)
Hiperpigmentación/inmunología , Mastocitos/inmunología , Prurito/inmunología , Enfermedades Cutáneas Genéticas/inmunología , Enfermedades Cutáneas Papuloescamosas/inmunología , Piel/citología , Biopsia , Análisis Mutacional de ADN , Diagnóstico Diferencial , Femenino , Glucosiltransferasas/genética , Antagonistas de los Receptores Histamínicos/administración & dosificación , Humanos , Hiperpigmentación/complicaciones , Hiperpigmentación/diagnóstico , Hiperpigmentación/genética , Queratina-5/genética , Mastocitos/efectos de los fármacos , Mastocitosis/diagnóstico , Mutación , Prurito/tratamiento farmacológico , Piel/inmunología , Piel/patología , Enfermedades Cutáneas Genéticas/complicaciones , Enfermedades Cutáneas Genéticas/diagnóstico , Enfermedades Cutáneas Genéticas/genética , Enfermedades Cutáneas Papuloescamosas/complicaciones , Enfermedades Cutáneas Papuloescamosas/diagnóstico , Enfermedades Cutáneas Papuloescamosas/genéticaRESUMEN
Familial dyskeratotic comedones is a well-known genodermatosis with autosomal dominant inheritance, characterized by numerous comedones with dyskeratosis in histology and scar formation in consequence. In contrast, cases of familial disseminated comedones without dyskeratosis appear to be extremely rare. So far, only three reports could be found in the literature. Here we describe a large family affected with disseminated comedones superimposed by moderate to severe acne. Remarkably, no signs of dyskeratosis were found in the histology taken from 2 of the 15 affected family members. We propose the diagnostic term 'familial disseminated comedones without dyskeratosis' to underline its familial and disseminated characteristics and discuss the differentiation with other similar entities.